Vascular Anomalies

  • H. Cremer
  • S. Thomsen


Vascular anomalies include both vascular tumors and vascular malformations. In the past, these two different disease processes were often not firmly separated, but the recommendations of the International Society for the Study of Vascular Anomalies in 1996 make it clear that such a division is desirable for proper diagnostic and therapeutic measures.


Vascular Malformation Vascular Anomaly Port Wine Stain Port Wine Rapid Growth Phase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Achauer B.M., Chang C.J., Vander-Kam V.M. Management of hemangioma of infancy: review of 245 patients. Plastic Reconstructive Surgery 99: 1301–1308 (1997)CrossRefGoogle Scholar
  2. Barlow R. J., Walker N. P.J., Markey A. C.: Treatment of proliferative hemangiomas with the 585 nm pulsed dye laser. British Journal of Dermatology 134:700–704 (1996)PubMedCrossRefGoogle Scholar
  3. Cooper J.G., Edward S. L., Holmes J.D.: Kaposiform haemangioendothelioma: case report and review of the literature. Br J Plast Surg 55:163–165 (2002)PubMedCrossRefGoogle Scholar
  4. Cremer H., Djawari D.: Hämangiomtherapie. Der Kinderarzt 27:491–499 (1996)Google Scholar
  5. Cremer H.: Vascular Tumors (Hemangiomas) in Childhood: in Chang J.B. (ed.), Textbook of Angiology. Springer New York (2000)Google Scholar
  6. Ezekowitz R. A. B., Mulliken J. B., Folkmann J.: Interferon α 2a for life threatening hemangiomas of infancy. New England Journal of Medicine 326:1456–1463 (1992)PubMedCrossRefGoogle Scholar
  7. Gangopadhyay A. N., Sinha C. K., Gopal S. C., Gupta D.K., Sahoo S.P., Ahmad M.: Role of steroids in childhood hemangioma: a 10 year review. International Surgery 82:49–51 (1997)PubMedGoogle Scholar
  8. Hohenleutner D., Bäumler W., Karrer S., Michel S., Landthaler M.: Die Behandlung kindlicher Hämangiome mit dem blitzlampengepumpten gepulsten Farbstofflaser. Hautarzt 47:183–189 (1996)PubMedCrossRefGoogle Scholar
  9. Kautz G., Cremer H. (Hrsg.) Härnangiorne. Diagnostik und Therapie in Bild und Text. Springer, Berlin, Heidelberg, New York (1999)Google Scholar
  10. Qu Z., Liebler J.M., Powers M. R., Galey T., Ahmadi P., Huang X. N., Ansel J.C., Butterfield J. H., Planck S. R., Rosenbaum J.T.: Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147:564–573 (1995)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Cremer
  • S. Thomsen

There are no affiliations available

Personalised recommendations